Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Tetrathiomolybdate |
| Trade Name | |
| Synonyms | CCRIS 9412|ATN-224 |
| Drug Descriptions |
Tetrathiomolybdate depletes systemic copper, thereby inhibiting cuproenzymes and leading to antitumor effects (PMID: 26160923, PMID: 32005716). |
| DrugClasses | |
| CAS Registry Number | 16330-92-0 |
| NCIT ID | C160684 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Capecitabine + Pembrolizumab + Tetrathiomolybdate | Capecitabine Pembrolizumab Tetrathiomolybdate | 0 | 1 |
| Capecitabine + Tetrathiomolybdate | Capecitabine Tetrathiomolybdate | 0 | 1 |
| Tetrathiomolybdate | Tetrathiomolybdate | 0 | 1 |